On May 19, 2016 Bayer reported that executives recently met with executives of Monsanto to privately discuss a negotiated acquisition of Monsanto Company (Press release, Bayer, MAY 18, 2016, View Source [SID:1234512567]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The proposed combination would reinforce Bayer as a global innovation-driven Life Science company with leadership positions in its core segments, and would create a leading integrated agriculture business.

This statement follows Monsanto’s announcement earlier today regarding a proposal from Bayer. A further statement will be made as appropriate.